189 related articles for article (PubMed ID: 28431200)
21. Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.
Scrivo R; Peruzzi G; Gattamelata A; Gross CC; Carletti R; Di Gioia C; Brandt J; Priori R; Morrone S; Santoni A; Valesini G
Cytometry B Clin Cytom; 2018 May; 94(3):412-422. PubMed ID: 28834234
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training.
Suzui M; Kawai T; Kimura H; Takeda K; Yagita H; Okumura K; Shek PN; Shephard RJ
J Appl Physiol (1985); 2004 Jun; 96(6):2167-73. PubMed ID: 14752119
[TBL] [Abstract][Full Text] [Related]
23. Terminal Differentiation of CD56(dim)CD16(+) Natural Killer Cells Is Associated with Increase in Natural Killer Cell Frequencies After Antiretroviral Treatment in HIV-1 Infection.
Ahmad F; Tufa DM; Mishra N; Jacobs R; Schmidt RE
AIDS Res Hum Retroviruses; 2015 Dec; 31(12):1206-12. PubMed ID: 26352913
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis and Summary of the Value of Immunophenotypes of Mature NK Cell Tumors for Differential Diagnosis, Treatment, and Prognosis.
Pu Q; Cao X; Liu Y; Yan D; Tan R; Li J; Yue B
Front Immunol; 2022; 13():918487. PubMed ID: 35812422
[TBL] [Abstract][Full Text] [Related]
25. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
26. Primary Immunodeficiencies Unravel the Role of IL-2/CD25/STAT5b in Human Natural Killer Cell Maturation.
Caldirola MS; Rodríguez Broggi MG; Gaillard MI; Bezrodnik L; Zwirner NW
Front Immunol; 2018; 9():1429. PubMed ID: 29988287
[TBL] [Abstract][Full Text] [Related]
27. Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C; Desmots F; Drillet G; Le Gallou S; Boulland ML; Thannberger A; Doncker AV; Salaun V; Damaj GL; Veyrat-Masson R; Tournilhac O; Moignet A; Pangault C; Roussel M; Fest T; Lamy T
Blood; 2021 Jun; 137(23):3237-3250. PubMed ID: 33512451
[TBL] [Abstract][Full Text] [Related]
28. Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.
Drénou B; Amiot L; Lamy T; Le Prisé PY; Fauchet R
Leuk Lymphoma; 1998 Jul; 30(3-4):381-7. PubMed ID: 9713968
[TBL] [Abstract][Full Text] [Related]
29. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
[TBL] [Abstract][Full Text] [Related]
30. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
31. Aggressive mature natural killer cell neoplasms: report on a series of 12 European patients with emphasis on flow cytometry based immunophenotype and DNA content of neoplastic natural killer cells.
Lima M; Spínola A; Fonseca S; Santos AH; Rodrigues J; Oliveira L; Queirós ML; Santos M; Gonçalves M; Lau C; Teixeira Mdos A; Gonçalves C; Marques C; Guerreiro M; Cunha M; Príncipe F; Coutinho J
Leuk Lymphoma; 2015 Jan; 56(1):103-12. PubMed ID: 24669939
[TBL] [Abstract][Full Text] [Related]
32. Aberrant NK cell associated marker (CD56 and CD57) expression in chronic lymphocytic leukemia.
Dorwal P; Mehra S; Pande A; Jain D; Smeeta G; Sachdev R; Raina V
Cytometry B Clin Cytom; 2015; 88(5):348-51. PubMed ID: 26013700
[TBL] [Abstract][Full Text] [Related]
33. Large granular lymphocyte proliferation with the natural killer-cell phenotype.
Chan WC; Gu LB; Masih A; Nicholson J; Vogler WR; Yu G; Nasr S
Am J Clin Pathol; 1992 Mar; 97(3):353-8. PubMed ID: 1543158
[TBL] [Abstract][Full Text] [Related]
34. Human CD56
Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J
Front Immunol; 2017; 8():699. PubMed ID: 28674534
[TBL] [Abstract][Full Text] [Related]
35. The CD16- CD56(bright) NK cell subset is resistant to reactive oxygen species produced by activated granulocytes and has higher antioxidative capacity than the CD16+ CD56(dim) subset.
Harlin H; Hanson M; Johansson CC; Sakurai D; Poschke I; Norell H; Malmberg KJ; Kiessling R
J Immunol; 2007 Oct; 179(7):4513-9. PubMed ID: 17878347
[TBL] [Abstract][Full Text] [Related]
36. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
37. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
[TBL] [Abstract][Full Text] [Related]
38. [NK-cell lymphomas and NK-like T-cell lymphomas].
Oshimi K
Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
[TBL] [Abstract][Full Text] [Related]
39. CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase.
Yang J; Li P; Piao Y; Liu X; Wei L; Sang W; Zhang L; Wang L
Front Immunol; 2022; 13():829366. PubMed ID: 35371002
[TBL] [Abstract][Full Text] [Related]
40. Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis.
Lima M
Orphanet J Rare Dis; 2013 Jul; 8():95. PubMed ID: 23816348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]